• Home
• Our Services
  • Early Phases
  • Late Phases
  • Biometrics
    • Data Management
    • Bio-Statistics
    • Pharmacovigilance
    • Pharmacoeconomics
  • Regulatory
  • Bio-Equivalence
  • Resourcing
  • Commercialization
  • Risk Sharing
  • Innovative Solutions
• News & Events
• About us
  • Company History
  • Corporate Leadership
• Contact us
  • How to contact us
  • How we can help you!
  • Where we can help you!
• Partners
  • DCRC
  • CEE-RI
  • Maximax International
  • Maximax Venture

MPR Inc. partners with Julphar Pharmaceutical Industries for the joint development of novel drugs.

:: HOME :: CONTACT US ::	COPYRIGHT MPR DEVELOPMENT GROUP 2002-

03-23-2008: Ras Al Khaimah, UAE.

MPR Inc. partners with Julphar Phamaceutical Industries for the joint development of novel drugs. As one of the leading generic manafacturers in MENA region, Julphar Phamaceutical Industries is well positioned to establish its capabilities towards developing novel drug portfolio. To strengthen its devleopment position, the Company decided to partner with MPR to enhance its capabilities in drug development and explore risk sharing programs with few of MPR clients.

The MENA region market is one of the largest in the world and Julphar with 9  manufacturing plants can offer international BioPharmaceutical companies strong contract manufacturing partner and easier access to these markets.

MPR and Julphar have initiated several projects in novel drug development and jointly seeking support from professioanl investors in the region.